PROVIDER PROFILE · NPI 1679563845

Bimalangshu DeyMD

Hematology-OncologyBoston, MAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

565

Unique beneficiaries

—

Total services

968

Distinct HCPCS

Medicare payment

$83K

Peer benchmark

Total Medicare services vs. 360 Hematology-Oncology providers in MA — above median (cohort median 624).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$342

Distinct drugs

Brand share

24.5%

Top prescribed drugs

Acyclovir14 claims

Prednisone14 claims

Sulfamethoxazole/Trimethoprim13 claims

Allopurinol12 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Bimalangshu Dey's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
EXETER HOSPITAL INC	90	598
THE GENERAL HOSPITAL CORPORATION	69	1,034
Thomas Spitzer Hematology-Oncology · Boston, MA	20	286
Yi-Bin Chen Medical Oncology · Boston, MA	19	260

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history